Skip to main content
OpenTrials

Clinical trial condition

Glioblastoma

Explore clinical trials studying Glioblastoma. Study availability and eligibility vary by location and protocol.

644 public trials 152 recruiting studies
Refine in advanced search Browse all conditions

Glioblastoma trial results

Active, Not Recruiting

A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence

NCT06336291

Conditions
Astrocytoma, Glioblastoma, Glioma, +7 more
Locations
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • Massachusetts General Hospital (MGH) Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center (BIDMC) Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute (DFCI) Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

AB154 Combined With AB122 for Recurrent Glioblastoma

NCT04656535

Conditions
Astrocytoma, Disease Attributes, Glioblastoma, +11 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Yale University New Haven, Connecticut, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Azeliragon in MGMT Unmethylated Glioblastoma

NCT05986851

Conditions
Astrocytoma, Glioblastoma, Glioma, +7 more
Locations
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Miami Cancer Institute - Baptist Health Miami, Florida, United States
  • Corewell Health Royal Oak, Michigan, United States
  • Washington University in St. Louis St Louis, Missouri, United States
View Trial Details
Active, Not Recruiting

SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

NCT02455557

Conditions
Astrocytoma, Glioblastoma, Glioma, +8 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Dana-Farber Harvard Cancer Center Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View Trial Details

Related conditions